Madrigal Pharmaceuticals Statistics
Total Valuation
MDGL has a market cap or net worth of $4.00 billion. The enterprise value is $3.78 billion.
Market Cap | 4.00B |
Enterprise Value | 3.78B |
Important Dates
The next confirmed earnings date is Tuesday, May 7, 2024, before market open.
Earnings Date | May 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
MDGL has 20.99 million shares outstanding. The number of shares has increased by 9.05% in one year.
Shares Outstanding | 20.99M |
Shares Change (YoY) | +9.05% |
Shares Change (QoQ) | +7.02% |
Owned by Insiders (%) | 9.24% |
Owned by Institutions (%) | 94.86% |
Float | 12.78M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 10.60 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.38, with a Debt / Equity ratio of 0.29.
Current Ratio | 5.38 |
Quick Ratio | n/a |
Debt / Equity | 0.29 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -28.39 |
Financial Efficiency
Return on equity (ROE) is -219.40% and return on invested capital (ROIC) is -72.82%.
Return on Equity (ROE) | -219.40% |
Return on Assets (ROA) | -98.80% |
Return on Capital (ROIC) | -72.82% |
Revenue Per Employee | n/a |
Profits Per Employee | -$993,697 |
Employee Count | 376 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -34.88% in the last 52 weeks. The beta is -0.44, so MDGL's price volatility has been lower than the market average.
Beta (1Y) | -0.44 |
52-Week Price Change | -34.88% |
50-Day Moving Average | 242.85 |
200-Day Moving Average | 201.69 |
Relative Strength Index (RSI) | 28.35 |
Average Volume (30 Days) | 589,532 |
Short Selling Information
The latest short interest is 3.36 million, so 16.02% of the outstanding shares have been sold short.
Short Interest | 3.36M |
Short Previous Month | 3.26M |
Short % of Shares Out | 16.02% |
Short % of Float | 26.32% |
Short Ratio (days to cover) | 4.79 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -380.50M |
Pretax Income | -373.63M |
Net Income | -373.63M |
EBITDA | -360.39M |
EBIT | -360.92M |
Earnings Per Share (EPS) | -$19.99 |
Balance Sheet
The company has $634.13 million in cash and $117.19 million in debt, giving a net cash position of $516.94 million or $24.62 per share.
Cash & Cash Equivalents | 634.13M |
Total Debt | 117.19M |
Net Cash | 516.94M |
Net Cash Per Share | $24.62 |
Equity / Book Value | 405.33M |
Book Value Per Share | 19.31 |
Working Capital | 518.73M |
Cash Flow
In the last 12 months, operating cash flow was -$324.23 million and capital expenditures -$1.48 million, giving a free cash flow of -$325.71 million.
Operating Cash Flow | -324.23M |
Capital Expenditures | -1.48M |
Free Cash Flow | -325.71M |
FCF Per Share | -$17.43 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
MDGL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -9.05% |
Shareholder Yield | -9.05% |
Earnings Yield | -8.70% |
FCF Yield | -7.58% |
Analyst Forecast
The average price target for MDGL is $355.36, which is 85.61% higher than the current price. The consensus rating is "Buy".
Price Target | $355.36 |
Price Target Difference | 85.61% |
Analyst Consensus | Buy |
Analyst Count | 12 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 25, 2016. It was a reverse split with a ratio of 1:35.
Last Split Date | Jul 25, 2016 |
Split Type | Reverse |
Split Ratio | 1:35 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |